解折蛋白反应的药理调制作为皮肤T细胞淋巴瘤的治疗方法
Nadia St Thomas1, Benjamin N Christopher1, Leticia Reyes1
1Department of Pharmacology and Immunology, Medical University of South Carolina, 173 Ashley Ave., MSC509, Charleston, SC 29425, USA.
Biomolecules
|January 25, 2025
概括
皮肤T细胞淋巴瘤 (CTCL) 细胞对蛋白酶体抑制剂高度敏感. 用特定的抑制剂 (如JG-023) 准未折叠蛋白质反应 (UPR) 对CTCL治疗有希望.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
背景情况:
- 皮肤T细胞淋巴瘤 (CTCL) 是一种罕见的皮肤癌,导致免疫缺陷.
- 展开的蛋白质反应 (UPR) 在T细胞发育和癌症中起作用.
- CTCL细胞表现出Th2免疫表型,导致患者感染.
研究的目的:
- 调查UPR诱导药物对CTCL的影响.
- 确定CTCL细胞对博尔特佐米布 (Btz) 的敏感性.
- 探索在CTCL中针对HSPA5/6的治疗潜力.
主要方法:
- 对比CTCL细胞和正常的CD4+细胞对博雷佐米布的反应.
- 使用了一种新的HSPA5/6抑制剂 (JG-023).
- 评估了对细胞活力,基因表达和细胞因子产生的影响.
主要成果:
- CTCL细胞对博尔特佐米布的敏感度超过正常T细胞的5倍.
- 在UPR诱导后,CTCL细胞显示HSPA6和HSPA5的表达增加.
- JG-023增强了博特佐米布的细胞毒性,并在CTCL中抑制了Th2细胞因子的产生.
- 用CTCL调节的介质通过IL-10抑制了正常的T细胞,而JG-023则逆转了这种情况.
结论:
- 在CTCL病理学中,UPR是至关重要的.
- 针对HSPA5/6和蛋白酶体抑制为CTCL提供了一个潜在的治疗策略.
- 针对UPR的药物可以逆转CTCL诱导的免疫抑制.
相关概念视频
Regulation of the Unfolded Protein Response
2.4K
Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.4K
The Unfolded Protein Response
4.4K
The ER is the hub of protein synthesis in a cell. It has robust systems to quality control protein folding and also for degradation of terminally misfolded proteins. Under normal conditions, a small proportion of misfolded proteins that cannot be salvaged need to be transported to the cytoplasm by the ER-associated degradation or ERAD pathways. However, if the ERAD cannot handle the misfolded proteins, the cell activates the unfolded protein response or UPR to adjust the protein folding...
4.4K
Inflammatory Bowel Disease IV: Pharmacological Management
106
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
106
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Receptor Downregulation in MVBs
2.0K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.0K
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
141
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
141


